• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[C]蛋氨酸PET在具有低级别组织学特征的异柠檬酸脱氢酶野生型弥漫性胶质瘤中的预后价值:突破世界卫生组织分类的探索

The prognostic power of [C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification.

作者信息

Ninatti Gaia, Pini Cristiano, Bono Beatrice Claudia, Gelardi Fabrizia, Antunovic Lidija, Fernandes Bethania, Sollini Martina, Landoni Claudio, Chiti Arturo, Pessina Federico

机构信息

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy.

出版信息

J Neurooncol. 2023 Sep;164(2):473-481. doi: 10.1007/s11060-023-04438-9. Epub 2023 Sep 11.

DOI:10.1007/s11060-023-04438-9
PMID:37695488
Abstract

PURPOSE

IDH-wildtype (IDH-wt) diffuse gliomas with histological features of lower-grade gliomas (LGGs) are rare and heterogeneous primary brain tumours. [C]Methionine (MET) positron emission tomography (PET) is commonly used to evaluate glial neoplasms at diagnosis. The present study aimed to assess the prognostic value of MET PET in newly diagnosed, treatment naïve IDH-wt gliomas with histological features of LGGs.

METHODS

Patients with a histological diagnosis of IDH-wt LGG who underwent preoperative (< 100 days) MET PET/CT and surgery were retrospectively included. Qualitative and semi-quantitative analyses of MET PET images were performed. Progression-free survival (PFS) and overall survival (OS) were analysed by Kaplan-Meier curves. Cox proportional-hazards regression was used to test the association of imaging and clinical data to PFS and OS.

RESULTS

We included 48 patients (M:F = 25:23; median age 55). 39 lesions were positive and 9 negative at MET PET. Positive MET PET was significantly associated with shorter median PFS (15.7 months vs. not reached, p = 0.0146) and OS time (32.6 months vs. not reached, p = 0.0253). Incomplete surgical resection and higher TBR values were independent predictors of shorter PFS on multivariate analysis (p < 0.001 for both). Higher tumour grade and incomplete surgical resection were independent predictors of OS at multivariate analysis (p = 0.027 and p = 0.01, respectively).

CONCLUSION

MET PET is useful for the prognostic stratification of patients with IDH-wt glial neoplasms with histological LGGs features. Considering their huge biological heterogeneity, the combination of MET PET and molecular analyses may help to improve the prognostic accuracy in these diffuse gliomas subset and influence therapeutic choices accordingly.

摘要

目的

具有低级别胶质瘤(LGG)组织学特征的异柠檬酸脱氢酶野生型(IDH-wt)弥漫性胶质瘤是罕见且异质性的原发性脑肿瘤。甲硫氨酸(MET)正电子发射断层扫描(PET)通常用于在诊断时评估胶质肿瘤。本研究旨在评估MET PET对新诊断的、未经治疗的具有LGG组织学特征的IDH-wt胶质瘤的预后价值。

方法

回顾性纳入组织学诊断为IDH-wt LGG且术前行(<100天)MET PET/CT及手术的患者。对MET PET图像进行定性和半定量分析。采用Kaplan-Meier曲线分析无进展生存期(PFS)和总生存期(OS)。使用Cox比例风险回归检验影像和临床数据与PFS及OS的相关性。

结果

我们纳入了48例患者(男:女 = 25:23;中位年龄55岁)。MET PET检查中39个病灶为阳性,9个为阴性。MET PET阳性与较短的中位PFS(15.7个月对未达到,p = 0.0146)和OS时间(32.6个月对未达到,p = 0.0253)显著相关。多因素分析显示,手术切除不完全和较高的肿瘤标准化摄取值(TBR)是PFS较短的独立预测因素(两者p均<0.001)。多因素分析显示,较高的肿瘤分级和手术切除不完全是OS的独立预测因素(分别为p = 0.027和p = 0.01)。

结论

MET PET对具有LGG组织学特征的IDH-wt胶质肿瘤患者的预后分层有用。鉴于其巨大的生物学异质性,MET PET与分子分析相结合可能有助于提高这些弥漫性胶质瘤亚组的预后准确性,并相应地影响治疗选择。

相似文献

1
The prognostic power of [C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification.[C]蛋氨酸PET在具有低级别组织学特征的异柠檬酸脱氢酶野生型弥漫性胶质瘤中的预后价值:突破世界卫生组织分类的探索
J Neurooncol. 2023 Sep;164(2):473-481. doi: 10.1007/s11060-023-04438-9. Epub 2023 Sep 11.
2
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.术前[11C]蛋氨酸 PET 对低级别胶质瘤患者治疗决策的个体化作用。
Neuro Oncol. 2022 Sep 1;24(9):1546-1556. doi: 10.1093/neuonc/noac040.
3
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[F]-fluoroethyl)-L-tyrosine PET.使用动态O-(2-[F]-氟乙基)-L-酪氨酸PET预测异柠檬酸脱氢酶野生型星形细胞瘤患者的生存率
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1486-1495. doi: 10.1007/s00259-020-04695-0. Epub 2020 Feb 7.
4
Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic F-FET PET.利用动态 F-FET PET 无创预测脑胶质瘤 IDH 野生型基因型。
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2581-2589. doi: 10.1007/s00259-019-04477-3. Epub 2019 Aug 13.
5
Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.根据2016年世界卫生组织中枢神经系统肿瘤分类,正电子发射断层扫描在鉴别胶质瘤中的应用价值。
J Neurosurg. 2019 Aug 16;133(4):1010-1019. doi: 10.3171/2019.5.JNS19780. Print 2020 Oct 1.
6
A Head-to-Head Comparison of F-Fluorocholine PET/CT and Conventional MRI as Predictors of Outcome in IDH Wild-Type High-Grade Gliomas.F-氟胆碱PET/CT与传统MRI作为异柠檬酸脱氢酶野生型高级别胶质瘤预后预测指标的头对头比较
J Clin Med. 2022 Oct 14;11(20):6065. doi: 10.3390/jcm11206065.
7
Diagnostic value of PET/CT with C-methionine (MET) and F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification.基于2016年世界卫生组织分类的¹¹C-蛋氨酸(MET)和¹⁸F-氟胸苷(FLT)PET/CT对新诊断胶质瘤的诊断价值
EJNMMI Res. 2020 May 7;10(1):44. doi: 10.1186/s13550-020-00633-1.
8
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.异柠檬酸脱氢酶野生型低级别弥漫性胶质瘤:组织学分级和分子评估对预后分层的重要性
Neuro Oncol. 2021 Jun 1;23(6):955-966. doi: 10.1093/neuonc/noaa258.
9
C-Methionine Integrated PET/MRI-Based Texture Analysis Features May Have a Potential Ability to Distinguish Oligodendroglioma (IDH-Mutant and 1p/19q-Codeleted) From Varied Gliomas.C-蛋氨酸整合 PET/MRI 纹理分析特征可能具有潜在的能力来区分少突胶质细胞瘤(IDH 突变和 1p/19q 缺失)与各种胶质瘤。
Acad Radiol. 2020 Jul;27(7):e159-e167. doi: 10.1016/j.acra.2019.09.013. Epub 2019 Oct 11.
10
Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.分子时代下低级别胶质瘤行大体全切除术后及初始观察时的进展风险因素。
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1099-1105. doi: 10.1016/j.ijrobp.2019.04.010. Epub 2019 Apr 22.

引用本文的文献

1
The determination of the boundaries and prediction the radicality of glioblastoma resection using MRI and CT perfusion.利用磁共振成像(MRI)和计算机断层扫描(CT)灌注成像确定胶质母细胞瘤切除的边界并预测其切除彻底性
Front Neurol. 2025 May 14;16:1572845. doi: 10.3389/fneur.2025.1572845. eCollection 2025.
2
Imply on diagnosis and early prognosis of preoperative [Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin.术前[镓]镓-PSMA-11 PET/CT对疑似胶质源性脑肿瘤患者的诊断及早期预后的意义。
Sci Rep. 2025 Jan 2;15(1):214. doi: 10.1038/s41598-024-84036-5.
3
Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [C]methionine PET.

本文引用的文献

1
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review.PET成像在成人型弥漫性胶质瘤放疗后放射性坏死与疾病复发鉴别诊断中的作用:一项系统评价
Cancers (Basel). 2023 Jan 5;15(2):364. doi: 10.3390/cancers15020364.
2
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.美国 2015-2019 年确诊的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95. doi: 10.1093/neuonc/noac202.
3
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.
采用[C]蛋氨酸 PET 对不同类型成人弥漫性胶质瘤的肿瘤进展与治疗相关变化进行个体化鉴别。
J Neurooncol. 2023 Dec;165(3):547-559. doi: 10.1007/s11060-023-04529-7. Epub 2023 Dec 14.
术前[11C]蛋氨酸 PET 对低级别胶质瘤患者治疗决策的个体化作用。
Neuro Oncol. 2022 Sep 1;24(9):1546-1556. doi: 10.1093/neuonc/noac040.
4
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
5
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.端粒酶逆转录酶(TERT)启动子突变状态对于诊断具有胶质母细胞瘤分子特征的异柠檬酸脱氢酶(IDH)野生型弥漫性星形细胞胶质瘤而言是必要且充分的。
Acta Neuropathol. 2021 Aug;142(2):323-338. doi: 10.1007/s00401-021-02337-9. Epub 2021 Jun 20.
6
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.异柠檬酸脱氢酶野生型低级别弥漫性胶质瘤:组织学分级和分子评估对预后分层的重要性
Neuro Oncol. 2021 Jun 1;23(6):955-966. doi: 10.1093/neuonc/noaa258.
7
Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes.使用机器学习对氟比他班PET图像进行分期和定量分析:预测的区域皮质示踪剂摄取和淀粉样蛋白分期对临床结果的影响。
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1971-1983. doi: 10.1007/s00259-019-04663-3. Epub 2019 Dec 28.
8
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.弥漫性星形细胞瘤,IDH1/2 野生型,具有胶质母细胞瘤的分子特征,WHO 分级 IV:对 cIMPACT-NOW 标准的确认。
Neuro Oncol. 2020 Apr 15;22(4):515-523. doi: 10.1093/neuonc/noz200.
9
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F]FDG: version 1.0.EANM/EANO/RANO 联合实践指南/SNMMI 程序标准:使用放射性标记氨基酸和 [F]FDG 的脑胶质瘤 PET 成像:第 1.0 版。
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557. doi: 10.1007/s00259-018-4207-9. Epub 2018 Dec 5.
10
LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity.LIFEx:一种用于多模态成像中放射组学特征计算的免费软件,可加速肿瘤异质性特征描述的进展。
Cancer Res. 2018 Aug 15;78(16):4786-4789. doi: 10.1158/0008-5472.CAN-18-0125. Epub 2018 Jun 29.